FDA Regulation
FDA Corrects Federal Register Notice on Withdrawal of Oxandrin (Oxandrolone) Tablets
The U.S. Food and Drug Administration issued a correction to a September 13, 2023 Federal Register notice (88 FR 62799) that had announced the withdrawal of Oxandrin (oxandrolone) tablets, 2.5 mg and 10 mg, from sale…
1 source5 claims checked7h ago
5 unverifiable
Biblical perspectiveINSUFFICIENT CONTEXT
Full analysis